Yoshiyasu Kisaka

Matsuyama, 7900067, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Publisher Correction: Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy.

Publisher Correction: Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy.

Journal: Journal of gastroenterology

Published: January 12, 2025

Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy.

Clinical factors to predict changes of esophagogastric varices after sustained viral response with direct-acting antiviral therapy.

Journal: Journal of gastroenterology

Published: March 19, 2024

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals.

Simple new clinical score to predict hepatocellular carcinoma after sustained viral response with direct-acting antivirals.

Journal: Scientific reports

Published: February 21, 2023

Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate.

Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagnosis and High Resection Rate.

Journal: Cancers

Published: December 30, 2022

AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy.

AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy.

Journal: BMC cancer

Published: October 22, 2020

ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer.

ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer.

Journal: Internal medicine (Tokyo, Japan)

Published: March 17, 2020

Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection.

Sex difference in the development of hepatocellular carcinoma after direct-acting antiviral therapy in patients with HCV infection.

Journal: Journal of medical virology

Published: January 21, 2020

Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance.

Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance.

Journal: Mayo Clinic proceedings

Published: August 09, 2018

Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection.

Predictors of hepatocellular carcinoma occurrence after direct-acting antiviral therapy in patients with hepatitis C virus infection.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 11, 2018

Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.

Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.

Journal: AJR. American journal of roentgenology

Published: February 08, 2018

Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.

Characteristics and Prognosis of Hepatocellular Carcinoma in Japanese Patients Undergoing Dialysis.

Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy

Published: January 06, 2017

Predictors of treatment efficacy and ALT non-normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2.

Predictors of treatment efficacy and ALT non-normalization with sofosbuvir/ribavirin therapy for patients with hepatitis C virus genotype 2.

Journal: Journal of medical virology

Published: October 26, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026